{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:51:39Z","timestamp":1700391099612},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":8118,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1987,2]]},"abstract":"<jats:p>The survival of 137 consecutive chronic lymphocytic leukemia patients, diagnosed between 1960 and 1982 and followed up at the Hematology Clinic of the Chaim Sheba Center, was correlated with demographic, clinical and laboratory data. The median survival time of the whole group was 104 months. Older age, hepatomegaly, anemia, thrombocytopenia and increased percent of lymphocytes in the peripheral blood at diagnosis were all associated with shorter survival. On the other hand, splenomegaly or lymph node enlargement did not influence survival. When divided according to both Rai's and the International Workshop staging systems, the survival of our patients seemed to be better than that reported in most previously published series of similar patients. We assume that this is related to a conservative approach to the treatment of chronic lymphocytic leukemia patients in this center.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1987.tb01149.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T12:43:19Z","timestamp":1279456999000},"page":"123-130","source":"Crossref","is-referenced-by-count":12,"title":["Survival and prognostic factors in chronic lymphocytic leukemia"],"prefix":"10.1111","volume":"38","author":[{"given":"Amos","family":"Pines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Ben\u2010Bassat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Modan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzvia","family":"Blumstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bracha","family":"Ramot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"709","volume-title":"Leukemia","author":"Spiers ASD","year":"1983"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0308-2261(21)00558-0","article-title":"Prognostic factors in chronic lymphocytic leukemia and their implications for therapy","volume":"6","author":"Phillips EA","year":"1977","journal-title":"Clin Hematol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02727.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-197907000-00001"},{"key":"e_1_2_1_8_2","first-page":"3","article-title":"Chronic lymphocytic leukemia: clinical studies based on 189 cases followed for a long time","volume":"18","author":"Hansen MM.","year":"1973","journal-title":"Scand J Haematol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V62.2.256.256","article-title":"Immunoglobulin phenotype on B cells correlates with clinical stage of chronic lymphocytic leukemia","volume":"62","author":"Ligler FS","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V65.2.340.340","article-title":"Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemia","volume":"65","author":"Baldini L","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02681.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198402023100504"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.1.134.134"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1980.tb02363.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07440.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841201)54:11<2450::AID-CNCR2820541123>3.0.CO;2-R"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(75)90389-7"},{"key":"e_1_2_1_18_2","first-page":"176","article-title":"Clinical and phenotypic features in patients with chronic lymphocytic leukemia (CLL): an analysis of prognostic factors [Abstract]","volume":"22","author":"Gajera R","year":"1983","journal-title":"Proc Am Assoc Clin Oncol"},{"key":"e_1_2_1_19_2","first-page":"1175","article-title":"Migration inhibition factors activity in sera of patients with chronic lymphocytic leukemia","volume":"63","author":"Benjamin D","year":"1979","journal-title":"JNCI"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood.V53.4.594.594","article-title":"Correlation of total body potassium and leukemia cell mass in patients with chronic lymphocytic leukemia","volume":"53","author":"Chandra P","year":"1979","journal-title":"Blood"},{"key":"e_1_2_1_21_2","first-page":"490","article-title":"Multi\u2010variate analysis of prognostic factors in chronic lymphocytic leukemia","volume":"21","author":"Prokocimer M","year":"1985","journal-title":"Isr J Med Sci"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/blood.V59.5.1001.1001","article-title":"Prognosis of chronic lymphocytic leukemia: a multivariate survival analysis of 150 cases","volume":"59","author":"Rozman C","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(66)90105-7"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","unstructured":"French Cooperative Group of Chronic Lymphocytic Leukaemia.Effectiveness of \u201cCHOP\u201d regimen in advanced untreated chronic lymphocytic leukaemia.Lancet1986;1346\u20139.","DOI":"10.1016\/S0140-6736(86)91663-6"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1987.tb01149.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1987.tb01149.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T22:34:44Z","timestamp":1697841284000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1987.tb01149.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1987,2]]}},"alternative-id":["10.1111\/j.1600-0609.1987.tb01149.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1987.tb01149.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,2]]}}}